Google sign-in. No card required.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity
Reporting to the Vice President, Global Analytics & Insights, the Executive Director, Global Data & Analytics will build and lead capabilities in disease and customer analytics, data governance, commercial data systems, portfolio analytics and reporting. The role will develop the team, tools and data foundations needed to support decisions from early development through commercialization across an expanding portfolio and geographic footprint.
This leader will partner with regional teams to identify shared needs, develop capabilities at global scale where this improves efficiency and impact, and facilitate support, reuse and knowledge sharing for capabilities built regionally. Working with Disease Area Insights, Forecasting and Information Systems, the Executive Director will translate business priorities into practical analytical solutions and trusted information for decision making. This position is based at our headquarters in Redwood City, CA.
Responsibilities:
-
Set the global Data & Analytics strategy and capability roadmap with regional partners and Information Systems. Identify unmet needs, prioritize investments and sequence development around business value, readiness and opportunities to create scale across disease areas and regions. Balance new capability development with capacity for ongoing delivery, maintenance and user support.
-
Build, coach and develop the Data & Analytics team and its leaders. Establish clear accountabilities, align resources with priorities and manage functional budgets, vendors and delivery.
-
Coordinate with regional analytics leaders to agree where global leads, jointly develops, supports or facilitates information sharing. Tailor support to local capabilities and needs, with clear ownership, funding, capacity and service expectations. Agree readiness criteria and continuity of support for transitions as capabilities evolve.
-
Develop shared analytical capabilities, reusable methods and tools where common needs justify global investment. Create forums and practical mechanisms to share regional innovations, expertise and lessons learned, enabling adaptation and adoption across markets.
-
Lead shared disease analytics capabilities and agreed analyses to understand patient populations, diagnosis and biomarker testing, treatment pathways, utilization and gaps in care. Integrate relevant data sources with regional expertise to inform disease area strategy, early product assessments, launch planning and lifecycle decisions.
-
Advance shared customer analytics methods, tools and specialist support to understand healthcare professional and account needs, behaviors and engagement. Partner with regional Analytics & Insights, Commercial and Commercial Excellence teams on segmentation, customer journeys and measurement of commercial activities. Agree ownership for each initiative, with regional teams leading market-specific application and recommendations unless otherwise agreed.
-
Provide analytical foundations, reusable methods and agreed analyses for portfolio assessments with Forecasting and Disease Area Insights, including overlapping populations, treatment